跳至主要内容
临床试验/NCT04945655
NCT04945655已完成不适用

Impact of a School- and Primary Care-based Multicomponent Intervention on HPV Vaccination Acceptability Among French Adolescents: a Cluster Randomized Controlled Trial

Institut National de la Santé Et de la Recherche Médicale, France1 个研究点 分布在 1 个国家目标入组 30,739 人开始时间: 2021年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30,739
试验地点
1
主要终点
HPV vaccine coverage (≥ 1 dose)

研究概览

简要总结

This study aims at evaluating the effectiveness, efficiency and implementation of a multicomponent intervention (components being applied in combination or alone) on the acceptability of HPV vaccine among French adolescents (11-14 years old) through a cluster randomized controlled trial. The primary outcome to measure acceptability is vaccine coverage. The three components are: adolescents and parents' education and motivation at school (component 1); general practitioners' training (component 2); and access to vaccination at school (component 3). Ninety municipalities are included and randomized into six groups of 15 municipalities, according an incomplete factorial plan.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Prevention
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Adolescents and parents' education and motivation at school (component 1 -- arms 1-4) and "KABP-6C" survey among adolescents and parents (arms 1-6)
  • Inclusion Criteria:
  • Adolescents (school years 9-10), and parents of adolescents (school years 7-10) attending secondary schools in the participating municipalities.

排除标准

  • General practitioners' training (component 2) and "KABP-6C" survey among general practitioners (arms 1, 2 and 5)
  • Inclusion Criteria:
  • General practitioners' practicing in the participating municipalities.
  • Exclusion Criteria:
  • Exclusive particular type of practice.
  • Planning to retire or move their practice within the study period.
  • No internet access.
  • Access to vaccination at school (component 3 -- arms 1 and 3)
  • Inclusion Criteria:
  • Adolescents (school years 7-10) attending secondary schools in the participating municipalities, aged 11-14 years (with a possible catch-up for those aged 15-19 years according to the French recommendations).
  • Exclusion Criteria:
  • Having initiated HPV vaccination.
  • No written consent from parents/caregivers for vaccination.
  • Contraindication to HPV vaccination.

结局指标

主要结局

HPV vaccine coverage (≥ 1 dose)

时间窗: 2 months after intervention

Percentage of adolescents aged 11-14 years, living in the municipality, who have received at least one dose of HPV vaccine

次要结局

  • HPV vaccine coverage (≥ 1 dose)(6 months and 12 months after intervention)
  • HPV vaccine coverage (2 doses)(2 months, 6 months and 12 months after intervention)
  • HPV vaccination intention(Before intervention and 2 months after intervention)
  • Intervention components' adaptation(Intervention components' implementation period)
  • Satisfaction of target populations about the activities / tools, assessed by a 4-point Likert scale(End of the intervention components' implementation period)
  • Knowledge, attitude, beliefs and practices towards HPV vaccination and psychological determinants of vaccination intention ("KABP-6C")(Before intervention and 2 months after intervention)
  • Incremental Cost-Effectiveness Ratio(2 months after intervention)
  • Reached populations(Intervention components' implementation period)
  • Intervention components' dose and fidelity(Intervention components' implementation period)

研究者

发起方
Institut National de la Santé Et de la Recherche Médicale, France
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验